• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化的调节性T细胞、功能失调的T细胞和衰老的T细胞会阻碍胰腺癌的免疫反应。

Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer.

作者信息

Sivakumar Shivan, Abu-Shah Enas, Ahern David J, Arbe-Barnes Edward H, Jainarayanan Ashwin K, Mangal Nagina, Reddy Srikanth, Rendek Aniko, Easton Alistair, Kurz Elke, Silva Michael, Soonawalla Zahir, Heij Lara R, Bashford-Rogers Rachael, Middleton Mark R, Dustin Michael L

机构信息

Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.

Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.

出版信息

Cancers (Basel). 2021 Apr 8;13(8):1776. doi: 10.3390/cancers13081776.

DOI:10.3390/cancers13081776
PMID:33917832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068251/
Abstract

Pancreatic cancer has one of the worst prognoses of any human malignancy and leukocyte infiltration is a major prognostic marker of the disease. As current immunotherapies confer negligible survival benefits, there is a need to better characterise leukocytes in pancreatic cancer to identify better therapeutic strategies. In this study, we analysed 32 human pancreatic cancer patients from two independent cohorts. A multi-parameter mass-cytometry analysis was performed on 32,000 T-cells from eight patients. Single-cell RNA sequencing dataset analysis was performed on a cohort of 24 patients. Multiplex immunohistochemistry imaging and spatial analysis were performed to map immune infiltration into the tumour microenvironment. Regulatory T-cell populations demonstrated highly immunosuppressive states with high TIGIT, ICOS and CD39 expression. CD8 T-cells were found to be either in senescence or an exhausted state. The exhausted CD8 T-cells had low PD-1 expression but high TIGIT and CD39 expression. These findings were corroborated in an independent pancreatic cancer single-cell RNA dataset. These data suggest that T-cells are major players in the suppressive microenvironment of pancreatic cancer. Our work identifies multiple novel therapeutic targets that should form the basis for rational design of a new generation of clinical trials in pancreatic ductal adenocarcinoma.

摘要

胰腺癌是所有人类恶性肿瘤中预后最差的疾病之一,白细胞浸润是该疾病的主要预后标志物。由于目前的免疫疗法对生存率的提升微乎其微,因此有必要更好地描述胰腺癌中的白细胞,以确定更好的治疗策略。在本研究中,我们分析了来自两个独立队列的32例人类胰腺癌患者。对8例患者的32000个T细胞进行了多参数质谱流式细胞术分析。对24例患者的队列进行了单细胞RNA测序数据集分析。进行了多重免疫组化成像和空间分析,以绘制免疫细胞浸润到肿瘤微环境中的情况。调节性T细胞群体表现出高度免疫抑制状态,TIGIT、ICOS和CD39表达较高。发现CD8 T细胞处于衰老或耗竭状态。耗竭的CD8 T细胞PD-1表达较低,但TIGIT和CD39表达较高。这些发现在一个独立的胰腺癌单细胞RNA数据集中得到了证实。这些数据表明,T细胞是胰腺癌抑制性微环境中的主要参与者。我们的工作确定了多个新的治疗靶点,这些靶点应为合理设计新一代胰腺癌导管腺癌临床试验奠定基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/2c500a2bce2c/cancers-13-01776-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/cce85203e59e/cancers-13-01776-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/06dcf5664a18/cancers-13-01776-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/aad46ffcfb37/cancers-13-01776-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/2c500a2bce2c/cancers-13-01776-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/cce85203e59e/cancers-13-01776-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/06dcf5664a18/cancers-13-01776-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/aad46ffcfb37/cancers-13-01776-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/8068251/2c500a2bce2c/cancers-13-01776-g004a.jpg

相似文献

1
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer.活化的调节性T细胞、功能失调的T细胞和衰老的T细胞会阻碍胰腺癌的免疫反应。
Cancers (Basel). 2021 Apr 8;13(8):1776. doi: 10.3390/cancers13081776.
2
The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma.TIGIT/CD155 的空间共存定义了胰腺导管腺癌中较差的生存和对辅助化疗的抵抗。
Theranostics. 2023 Aug 18;13(13):4601-4614. doi: 10.7150/thno.86547. eCollection 2023.
3
Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade.胰腺导管腺癌中的组织驻留记忆 T 细胞共表达 PD-1 和 TIGIT,双重抗体阻断可使其功能可逆。
Cancer Immunol Res. 2023 Apr 3;11(4):435-449. doi: 10.1158/2326-6066.CIR-22-0121.
4
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer.TIGIT 表达可区分胰腺癌中具有不同功能和预后影响的 T 细胞群体。
Clin Cancer Res. 2023 Jul 14;29(14):2638-2650. doi: 10.1158/1078-0432.CCR-23-0258.
5
Identification of clinically relevant subsets CD39PD-1CD8 T cells and CD39 regulatory T cells in intrahepatic cholangiocarcinoma using single-cell CyTOF.使用单细胞质谱流式细胞术鉴定肝内胆管癌中临床相关的亚群CD39⁺PD-1⁺CD8⁺ T细胞和CD39⁺调节性T细胞
Transl Oncol. 2024 Jun;44:101954. doi: 10.1016/j.tranon.2024.101954. Epub 2024 Apr 11.
6
Location of CD39 T cell subpopulations within tumors predict differential outcomes in non-small cell lung cancer.肿瘤内 CD39 T 细胞亚群的位置预测非小细胞肺癌的不同预后。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-006770.
7
Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.单细胞质谱流式细胞术揭示的人胰腺导管腺癌的局部和全身免疫特征。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004638.
8
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.解析胰腺导管腺癌免疫微环境中各成分和特征的预后意义。
Front Immunol. 2021 Mar 10;12:648917. doi: 10.3389/fimmu.2021.648917. eCollection 2021.
9
Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer.人类胰腺癌的肿瘤和外周血免疫景观的多模态图谱。
Nat Cancer. 2020 Nov;1(11):1097-1112. doi: 10.1038/s43018-020-00121-4. Epub 2020 Oct 26.
10
Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer.卵巢癌中同时表达CD39、CD103和PD-1的肿瘤浸润淋巴细胞的单细胞图谱及预后影响
Clin Cancer Res. 2021 Jul 15;27(14):4089-4100. doi: 10.1158/1078-0432.CCR-20-4394. Epub 2021 May 7.

引用本文的文献

1
Novel Insights into T-Cell Exhaustion and Cancer Biomarkers in PDAC Using ScRNA-Seq.利用单细胞RNA测序对胰腺导管腺癌中T细胞耗竭和癌症生物标志物的新见解
Biology (Basel). 2025 Aug 7;14(8):1015. doi: 10.3390/biology14081015.
2
An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial.免疫反应性肿瘤微环境在外周血单核细胞中留下印记并预测晚期胰腺癌的预后:来自PREDICT试验的经验教训。
Mol Cancer. 2025 Jul 22;24(1):202. doi: 10.1186/s12943-025-02406-7.
3
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer.

本文引用的文献

1
Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer.人类胰腺癌的肿瘤和外周血免疫景观的多模态图谱。
Nat Cancer. 2020 Nov;1(11):1097-1112. doi: 10.1038/s43018-020-00121-4. Epub 2020 Oct 26.
2
The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance.胰腺癌分子亚型、组织学与微环境的匹配及其与化疗耐药性的相关性
Cancers (Basel). 2021 Jan 17;13(2):322. doi: 10.3390/cancers13020322.
3
Cancer Statistics, 2021.癌症统计数据,2021.
对RNA具有结合能力且能穿透细胞的抗体进行全身给药,可将治疗性RNA靶向多种癌症小鼠模型。
Sci Transl Med. 2025 Jul 16;17(807):eadk1868. doi: 10.1126/scitranslmed.adk1868.
4
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia.空间蛋白质组学和转录组学揭示胰腺上皮内瘤变中早期免疫细胞组织。
JCI Insight. 2025 Jun 26;10(15). doi: 10.1172/jci.insight.191595. eCollection 2025 Aug 8.
5
CD3+ T-cell: CD14+ monocyte complexes are dynamic and increased with HIV and glucose intolerance.CD3+ T细胞:CD14+单核细胞复合物是动态变化的,且在感染HIV和糖耐量异常时会增加。
J Immunol. 2025 Feb 28;214(3):516-31. doi: 10.1093/jimmun/vkae054.
6
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms.胰腺导管腺癌(PDAC)中不同的免疫细胞浸润模式表现出不同的免疫细胞选择和免疫抑制机制。
Nat Commun. 2025 Feb 6;16(1):1397. doi: 10.1038/s41467-024-55424-2.
7
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.TNFR2 阻断通过靶向激活的 Treg 和减少 T 细胞耗竭促进 PDAC 的抗肿瘤免疫反应。
J Immunother Cancer. 2024 Nov 19;12(11):e008898. doi: 10.1136/jitc-2024-008898.
8
A novel method for characterizing cell-cell interactions at single-cell resolution reveals unique signatures in blood T cell-monocyte complexes during infection.一种在单细胞分辨率下表征细胞间相互作用的新方法揭示了感染期间血液中T细胞-单核细胞复合物的独特特征。
bioRxiv. 2024 Sep 23:2024.09.20.612103. doi: 10.1101/2024.09.20.612103.
9
Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models.胰腺癌患者来源异种移植模型的遗传学及对肿瘤浸润淋巴细胞治疗的反应
Gastro Hep Adv. 2022 Jul 15;1(6):1037-1048. doi: 10.1016/j.gastha.2022.07.006. eCollection 2022.
10
Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?调控调节性 T 细胞:这是为胰腺导管腺癌解锁有效免疫治疗的关键吗?
Front Immunol. 2024 May 30;15:1406250. doi: 10.3389/fimmu.2024.1406250. eCollection 2024.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
Immunomodulation in Pancreatic Cancer.胰腺癌中的免疫调节
Cancers (Basel). 2020 Nov 12;12(11):3340. doi: 10.3390/cancers12113340.
5
The Immune Microenvironment in Pancreatic Cancer.胰腺癌中的免疫微环境。
Int J Mol Sci. 2020 Oct 3;21(19):7307. doi: 10.3390/ijms21197307.
6
An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression.一种针对 ICOS 的抗体增加了肿瘤内细胞毒性 T 细胞与调节性 T 细胞的比例,并诱导肿瘤消退。
Cancer Immunol Res. 2020 Dec;8(12):1568-1582. doi: 10.1158/2326-6066.CIR-20-0034. Epub 2020 Sep 30.
7
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.肺癌中的肿瘤突变塑造了 T 细胞分化的景观。
Nat Cancer. 2020 May;1(5):546-561. doi: 10.1038/s43018-020-0066-y. Epub 2020 May 22.
8
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities.胰腺癌的肿瘤微环境——临床挑战与机遇。
Nat Rev Clin Oncol. 2020 Sep;17(9):527-540. doi: 10.1038/s41571-020-0363-5. Epub 2020 May 12.
9
CD226CD8 T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.CD226CD8 T 细胞是抗 TIGIT 免疫治疗的前提条件。
Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7.
10
Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer.胰腺导管内乳头状黏液性肿瘤进展为浸润性癌过程中免疫景观的演变。
EBioMedicine. 2020 Apr;54:102714. doi: 10.1016/j.ebiom.2020.102714. Epub 2020 Apr 4.